Terapia génica humana: Tendencias y problemas actuales

Medicina Clinica

Volumn 106, Issue 12, 1996, Pages 469-476

  Lazo, Pedro A ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADENOVIRUS; COMPARATIVE STUDY; CYSTIC FIBROSIS; GENE THERAPY; GENETIC ENGINEERING; GENETICS; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; METHODOLOGY; RETROVIRUS; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADENOVIRIDAE; CYSTIC FIBROSIS; DNA, VIRAL; GENE THERAPY; GENETIC ENGINEERING; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; RETROVIRIDAE;

EID: 2542624899     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Miller AD Human gene therapy comes of age Nature (Lond) 1992, 357. 455-460.
2. Anderson WF Human gene therapy. Science 1992; 256 808-813.
3. Weissman SM. Gene therapy Proc Nat) Acad Sci USA 1992; 89. 11.111-11.112.
4. Mulligan RC. The basic science of gene therapy. Science 1993; 260. 926-932
5. Morgan RA, Anderson WF. Human gene therapy Ann Rev Biochem 1993; 62: 191-217
6. Kessler DA, Siegel JP, Noguchi PD, Zoon KC, Feiden KL, Woodcock J Regulation of somatic-cell therapy and gene therapy by the Food and Drug Administration. N Engl J Med 1993, 329. 1 169-1.173.
7. Culver KW, Blaese RM Gene therapy for cancer. Trends Genet 1994; 10: 174-178
8. Gilboa E. Smith C. Gene therapy for infectious diseases the AIDS model. Trends Gent 1994, 10 139-144
9. Wivel NA, Waiters L Germ-line gene modification and disease prevention: some medical and ethical perspectives. Science 1993 262. 533-538
10. Kay MA. Woo SLC Gene therapy for metabolic disorders Trends Genet 1994, 10- 253-257
11. Nowak R Genetic testing set for takeoff. Sciente 1994, 265: 464-467.
12. Schenker JG. Pre-embryo- therapeutic approaches Ann Med 1993; 25 265-270
13. Miller HI. Gene therapy for enhancement Lancet 1994, 344. 316-317.
14. Carmen IH. Human gene therapy: a biopolitical overview and analysis. Hum Gene Ther 1993; 4: 187-193
15. Porteous DJ, Dorin JR. Gene therapy for cystic fibrosis, where and when' Hum Gene Ther 1993; 2: 211-212.
16. Collins FS Cystic fibrosis: molecular biology and therapeutic implications Science 1992, 256: 774-779
17. Coumoyer D, Caskey CT Gene therapy of the immune system Ann Rev Immunol 1993; 11: 297-329
18. Lozier JN, Bnnkhous KM. Gene therapy and the hemophilhas. JAMA 1994, 271 47-51.
19. Gerrard AJ, Hudson DL, Brownlee GG, Watt FM. Towards gene therapy for haemophilia B using primary human keratmocytes. Nat Genet 1993; 3: 180-183
20. Hoeben RC, Fallaux FJ, Van Tilburg NH, Crarner SJ, Van Orrnondt H, Bnet E, Van et al. Toward gene therapy for hemophilia A long term persistence of factor VIII-secreting fibroblasts after transplantation into immunodeficient mice Hum Gene Ther 1993; 4: 179-186.
21. Beutler E Gaucher disease: new molecular approaches to diagnosis and treatment. Science 1992; 256: 794-799.
22. Grossman M, Raper SE, Kozarsky K, Stein EA, Engelhardt JF, Muller D et al Successful ex vivo gene therapy directe to liver in a patient with familial hypercholesterolaemia. Nat Genet 1994; 6: 335-341.
23. Yang Y, Raper SE, Cohn JA, Engelhardt JF, Wilson JM An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer Proc Natl Acad Sci USA 1993; 90: 4.601-4.605.
24. Davis HL, Whalen RG, Demeneix BA. Direct gene transfer into skeletal muscle in vivo, factors affecting efficiency of transfer and stability of expression. Hum Gene Ther 1993; 4: 151-159
25. Ohno T, Gordon D, San H, Pompili VJ, Imperiale MJ, Navel GJ et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury Science 1994; 265: 781-784.
26. Friedmann T. Gene therapy for neurological disorders. Trends Genet 1994, 10: 210-214.
27. Salmons B, Gunzburg WH. Targeting of retroviral vectors for gene therapy. Hum Gene Ther 1993; 4 129-141
28. Akli S, Caillaud C, Vigne E, Stratford-Perricaudet LD, Poenaru L, Perricaudet M et al Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet 1993; 3: 224-228
29. Hwu P, Yannelli J, Knegler M, Anderson WF, Pérez C, Chiang Y et al. Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-α cDNA for the gene therapy of cancer in humans. J Immunol 1993, 150: 4.104-4.105.
30. Alton EWFW, Middleton PG, Caplen NJ, Smit SN, Steel DM, Munkonge FM et al Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosts mutant mice Nat Genet 1993; 5: 135-142.
31. Tischlis PN, Lazo PA. Virus-host interactions and the pathogenests of murine and human oncogenic retroviruses. Curr Top Microbiol Immunol 1991, 171 95-171
32. Samulski RJ. Adeno-associated virus: integration at specific chromosomal locus. Curr Opin Genet Develop 1993, 3: 74-80.
33. Boris-Lawrie KA, Temin HM. Recent advances in retrovirus vector technology. Curr Opin Genet Develop 1993; 3: 102-109.
34. Temin HM. Safety considerations in somatic gene therapy of human disease with retrovirus veclors. Hum Gene Therapy 1990, 1: 111-123.
35. Burns JC, Friedman T, Driever W, Burrascano M, Yee J-K Vesicular stomatitis virus by glycoproteins pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and non mammalian cells. Proc Natl Acad Sci USA 1993; 90: 8.033-8.037.
36. Engelhardt JF, Yang Y, Stratford-Perricaudet LD, Allen ED, Kozarsky K, Perricaudet M et al. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with El-deleted adenoviruses Nat Genet 1993; 4. 27-34.
37. Yang Y, Nunes FA, Berenesi K, Gonczol E, Engelhardt JF, Wilson JM. Inacivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis Genet 1994; 7. 362-369
38. Le Gal La Salle G, Robert JJ, Berrard S, Ridoux V, Statford-Perricaudet LD, Perricaudet M et al. An adenovirus vector for gene transfer into neurons and glia in the brain Science 1993: 259 988-990.
39. Bajocchi G, Feidman SH, Crystal RG, Mastrangeli A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genet 1993; 3. 187-189
40. Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Daiemans W et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium Cell 1992, 68: 143-155.
41. Ledley FD, Adams RM, Sonano HE, Darlington G, Finegold M, Lanfrod R et al. Development of a clinical protocol for hepatic gene transfer leasons learned from preclinical studies. Pediatr Res 1993; 33: 313-320.
42. Huxley C Mammalian artificial chromosomes: a new tool for gene therapy. Gene Therapy 1994; 1 7-12.
43. Férec C, Mercier B. Andrézet M-P Les mutations de la mucoviscidose. du génotype au phenotype- Med Sci 1994; 10: 631-639.
44. Dorin JR, Dickinson P, Alton EWFW, Smith SN, Geddes DM, Stevenson BJ et al Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature (Lond) 1992; 359: 211-215
45. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993; 9: 138-141.
46. Espinosa E, González-Barón M, Espinosa J. Terapia genética del cáncer. Bases para su comprensión- Med Clin (Barc) 1994; 102. 228-230
47. Yu M, Poeschla E, Wong-Staal F. Progress towards gene therapy for HIV infection Gene Therapy 1994; 1: 13-26
48. Marasco WA, Haseltine WA, Chen SY Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody Proc Natl Acad Sci USA 1993; 90: 7 879-7.893
49. Trono D, Feinberg MB, Baltimore D HIV-1 gag mutant can dominantly interfere with the replication of the wild-type virus. Cell 1989, 59: 113-120
50. Mahm MH, Freimuth WW, Liu J, Boyle TJ, Lyerly HK, Cullen BR et al Stable expression of transdominant rev protein in human T cells inhibits human immunodeficiency virus replication. J Exp Med 1992, 176 1.197-1.201
51. Yamada O, Yu M, Yee J-K, Kraus G, Looney G, Wong-Staal F. Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1. Gene Therapy 1994; 1 38-45.
52. + cells by a recombinant human immunodeficiency virus retroviral vector. J Clin Invest 1991, 88: 1.043-1.047.